secwatch.observer — SEC 8-K summary
======================================

Issuer:     RELMADA THERAPEUTICS, INC. (RLMD)
CIK:        0001553643
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001213900-23-074165
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Eric Schmidt resigns; cites compliance for new sell-side analyst role
--------------------------------------------------------------------------------

- Eric Schmidt resigned from the Board effective September 5, 2023, with no disagreement with the company or management.
- Resignation due to compliance requirements from his new role as a sell-side equity analyst at a Wall Street investment banking firm.
- Schmidt served as a Class I director since 2019, chaired the Audit Committee, and was on the Governance Committee.
- No replacement has been announced for the vacant board position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/0001213900-23-074165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553643/000121390023074165/ea184757-8k_relmada.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-074165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer